Dr. Barry Ticho is a pediatric cardiologist who possesses deep knowledge of cardiovascular drug development and expertise in pharmacology, drug delivery and nucleic acid technologies. He currently serves as chief medical officer at Stoke Therapeutics. Prior to joining Stoke, Barry was head of development of mRNA treatments for cardiovascular and metabolic diseases at Moderna Therapeutics. Previously, he served as head of external research and development innovation for cardiovascular and metabolic diseases at Pfizer and, before that, was vice president of clinical development at Biogen. He has also served as a member of the clinical staff at Harvard Medical School.
Barry holds an M.D. and Ph.D. from the University of Chicago. He completed pediatrics training at Northwestern University and a cardiology fellowship at Boston Children’s Hospital.